Abstract
Patient nonadherence refers to a lack of coincidence between the patient ’s behavior and clinical prescriptions. At each step in the doctor -patient encounter—from making a first appointment , to undergoing screening tests, to taking medications and accepting changes in lifestyle , adherence is an issue: For instance, roughly half of the medication prescriptions are not filled. Nonadherence has been demonstrated repeatedly to erode the effectiveness of medical care and is linked with an increased rate in mortality. It has a major impact on health expenditures. A WHO report concluded that “increasing the effectiveness of adherence interventions may have a far greater impact on the health of the population than any improvement in specific medical treatment.” In this book, I shall try to understand in general the phenomenon of nonadherence. To achieve this goal, I will attempt to describe what our patients are doing when they are adherent, for example, when they come to an office visit, take a tablet, stay on a diet or refuse a cigarette . These various manifestations of adherence must have something in common, i.e. their homology: My goal is precisely to discover what makes these phenomena homologous, without losing sight of differences. This will lead me to suggest that in each one of these cases we are dealing with not just a behavior , but an action . Thus I shall propose an interpretation of the mental mechanisms of adherence to long-term therapies based on the philosophy of human agency: Mind and Care.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsNotes
- 1.
I am grateful to John Meyers for this remark.
- 2.
An illustration given by John Meyers.
References
Blackwell B, editor. Treatment compliance and the therapeutic alliance. Amsterdam: Harwood Academic Publishers; 1997.
Briesacher BA, Andrade SE, Fouayzi H, Chan KA. Comparison of drug adherence rates among patients with seven different medical conditions. Pharmacotherapy. 2008;28:437–43.
Cavanaugh K, Huizinga MM, Wallston KA, Gebretsadik T, Shintani A, Davis D, Gregory RP, Fuchs L, Malone R, Cherrington A, Pignone M, DeWalt DA, Elasy TA, Rothman RL. Association of numeracy and diabetes control. Ann Intern Med. 2008;148:737–46.
Cramer JA. A systematic review of adherence with medication for diabetes. Diabetes Care. 2004;27:1218–24.
Curtis JR, Xi J, Westfall AO, Cheng H, Lyles K, Saag KG, Delzell E. Improving the prediction of medication compliance: the example of bisphosphonates for osteoporosis. Med Care. 2009;47:334–41.
Eaddy MT, Cook CL, O’Day K, Burch SP, Cantrell CR. How patient cost-sharing trends affect adherence and outcomes: a literature review. PT. 2012;37:45–55.
Elster J, Skog O-J, editors. Getting hooked, rationality and addictions. Cambridge: Cambridge University Press; 1999.
Engel P. Foreword to his translation of Donald Davidson’s paradoxes of irrationality, Éditions L’Éclat; 1991.
Haynes RB, Taylor DW, Sackett DL. Compliance in health care. Baltimore: Johns Hopkins University Press; 1979.
Haynes RB, Ackloo E, Sahota N, McDonald HP, Yao X. Interventions for enhancing medication adherence. Cochrane Database Syst Rev. 2008;2(2):CD000011.
Ho PM, Rumsfeld JS, Masoudi FA, McClure DL, Plomondon ME, Steiner JF, Magid DJ. Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus. Arch Intern Med. 2006;166:1836–41.
Horwitz RI, Viscoli CM, Berkman L, Donaldson RM, Horwitz SM, Murray CJ, Ransohoff DF, Sindelar J. Treatment adherence and risk of death after myocardial infarction. Lancet. 1990;336:542–5.
Iuga AO, McGuire MJ. Adherence and health costs. Risk Manag Healthc Policy. 2014;7:35–44.
Lawrence DB, Ragucci KR, Long LB, Parris BS, Helfer LA. Relationship of oral antihyperglycemic (sulfonylurea or metformin) medication adherence and hemoglobin A1c goal attainment for HMO patients enrolled in a diabetes disease management program. J Manag Care Pharm. 2006;12:466–71.
Lee WC, Balu S, Cobden D, Joshi AV, Pashos CL. Prevalence and economic consequences of medication adherence in diabetes: a systematic literature review. Manag Care Interface. 2006;19:31–4.
Lutfey KE, Wishner WJ. Beyond “compliance” is “adherence”, improving the prospect of diabetes care. Diabetes Care. 1999;22:635–9.
McNabb WL. Adherence in diabetes: can we define it and can we measure it? Diabetes Care. 1997;20:216–8.
Meichenbaum D, Turk DC. Factors affecting adherence. In: Facilitating treatment adherence. New York: Plenum Press; 1987.
Pears D. Motivated irrationality. South Bend: St Augustine’s Press; 1998.
Ramsey FP. In: Mellor DH (ed) Philosophical papers. Cambridge: Cambridge University Press; 1990.
Reach G. Linguistic barriers in diabetes care. Diabetologia. 2009;52:1461–3.
Reach G. Obedience and motivation as mechanisms for adherence to medication. A study in obese type 2 diabetic patients. Patient Prefer Adherence. 2011;5:523–31.
Rovelli M, Palmeri D, Vossler E, Bartus S, Hull D, Schweizer R. Compliance in organ transplant recipients. Transplant Proc. 1989;21:33–844.
Sabaté E (ed). World Health Organization report. Adherence to long-term therapies, evidence for action, Geneva, Switzerland; 2003.
Simpson SH, Eurich DT, Majumdar SR, Padwal RS, Tsuyuki RT, Varney J, Johnson JA. A meta-analysis of the association between adherence to drug therapy and mortality. BMJ. 2006;333:15.
Sokol MC, McGuigan KA, Verbrugge RR, Epstein RS. Impact of medication adherence on hospitalization risk and healthcare cost. Med Care. 2005;43:521–30.
Urquhart J. Pharmacoeconomic impact of variable compliance. In: Metry JM, Meyer UA, editors. Drug regimen compliance: issues in clinical trials and patient management. Chichester: Wiley; 1999.
Vermeire E, Wens J, Van Royen P, Biot Y, Hearnshaw H, Lindenmeyer A. Interventions for improving adherence to treatment recommendations in people with type 2 diabetes mellitus. Cochrane Database Syst Rev. 2005;18:CD003638.
Wise RA, Bozarth MA. A psychomotor stimulant theory of addiction. Psychol Rev. 1987;94:469–92.
Woolf SH, Johnson RE. The break-even point: when medical advances are less important than improving the fidelity with which they are delivered. Ann Fam Med. 2005;3:545–52.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Reach, G. (2015). Introduction: The Doctor , Her Patient , and Their Reasons. In: The Mental Mechanisms of Patient Adherence to Long-Term Therapies. Philosophy and Medicine, vol 118. Springer, Cham. https://doi.org/10.1007/978-3-319-12265-6_1
Download citation
DOI: https://doi.org/10.1007/978-3-319-12265-6_1
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-12264-9
Online ISBN: 978-3-319-12265-6
eBook Packages: Humanities, Social Sciences and LawPhilosophy and Religion (R0)